Izokibep: still enthused about enthesitis?

Oct 29, 2025 4:04 pm

Dr. Aurelie Najm reports on abstract LB08 (Efficacy and Safety of Izokibep, a Novel IL-17A Inhibitor, in Patients with Active Psoriatic Arthritis: Week 52 Results from a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b/3 Study) presented at the 2025 ACR Convergence meeting in Chicago